Abstract
Skin cancer is a common cancer and is associated with significant morbidity and mortality. Topical treatment is an attractive option compared with systemic route due to the reduced association with systemic toxicity. Nonetheless, skin is a natural barrier under physiological conditions for topical drug delivery as it is crucial to provide protection to the body. Such barrier will limit the drug uptake into skin. Common strategies consisting of physical and chemical approaches to overcome this have been reported to improve topical delivery efficacy. However, safety concerns caused by possible irreversible skin damage remain. Due to the heterogeneous physical and chemical property of the skin, current methods limits the variety of drugs suitable for effective delivery into skin. Here, in this review, we showed the promise in engineering lipidic nanoparticles in treating skin cancer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Incidence and mortality web-based report. Human Services, Centers for Disease Control and Prevention, and National Cancer Institute. Atlanta, GA: Department of Health and United States Cancer Statistics: 1999–2007; 2010. http://www.cdc.gov/uscs.
Krathen RA, Orengo IF, Rosen T. Cutaneous metastasis: a meta-analysis of data. South Med J. 2003;96(2):164–7.
Spencer PS, Helm TN. Skin metastases in cancer patients. Cutis. 1987;39(2):119–21.
Barry BW. Breaching the skin’s barrier to drugs. Nat Biotechnol. 2004;22:165–7.
Micali G, Lacarrubba F, Dinotta F, Massimino D, Nasca MR. Topical cream for treating cancer. Expert Opin Pharmacother. 2010;11(9):1515–27.
Arias JL. Novel strategies to improve the anticancer action of 5-fluorouracil by using drug delivery systems. Molecules. 2008;13(10):2340–69.
On regulatory aspects of nanomaterials. In: Scientific Committee on Consumer Products, European Commission; 2008. http://www.europarl.europa.eu/sides/getDoc.do?pubRef=-//EP//NONSGML+REPORT+A6-2009-0255+0+DOC+PDF+V0//EN.
Zvyagin AV, Zhao X, Gierden A, Sanchez W, Ross JA, Roberts MS. Imaging of zinc oxide nanoparticle penetration in human skin in vitro and in vivo. J Biomed Opt. 2008;13(6):064031.
Labouta HI, El-Khordagui LK, Kraus T, Schneider M. Mechanism and determinants of nanoparticle penetration through human skin. Nanoscale. 2011;3:4989–99.
Ryman-Rasmussen JP, Riviere JE, Monteiro-Riviere NA. Variables influencing interactions of untargeted quantum dot nanoparticles with skin cells and identification of biochemical modulators. Nano Lett. 2007;7:1344–8.
Baroli B, Ennas MG, Loffredo F, Isola M, Pinna R, Lopez-Quintela MA. Penetration of metallic nanoparticles in human full-thickness skin. J Invest Dermatol. 2007;127:1701–12.
Anigbogu AN, Williams AC, Barry BW. Permeation characteristics of 8-methoxypsoralen through human skin; relevance to clinical treatment. J Pharm Pharmacol. 1996;48:357–66.
Moens E, Veldhoen M. Epithelial barrier biology: good fences make good neighbours. Immunology. 2012;135:1–8.
Nino M, Calabrò G, Santoianni P. Topical delivery of active principles: the field of dermatological research. Dermatol Online J. 2010;16(1):4.
Dhiman S, Singh TG, Rehni AK. Transdermal patches: a recent approach to new drug delivery system. Int J Pharm Pharm Sci. 2011;3(5):26–34.
Gamer AO, Leibold E, Ravenzwaay VB. The in vitro absorption of microfine zinc oxide and titanium dioxide through porcine skin. Toxicol In Vitro. 2006;20(3):301–7.
Jackson B, Brown SJ, Avilion AA, O’Shaughnessy RF, Sully K, Akinduro O, Murphy M, Cleary ML, Byrne C. TALE homeodomain proteins regulate site-specific terminal differentiation, LCE genes and epidermal barrier. J Cell Sci. 2011;124(Pt 10):1681–90.
Matsuki M, Yamashita F, Ishida-Yamamoto A, Yamada K, Kinoshita C, Fushiki S, et al. Defective stratum corneum and early neonatal death in mice lacking the gene for transglutaminase 1 (keratinocyte transglutaminase). Proc Natl Acad Sci U S A. 1998;95(3):1044–9.
Scheuplein RJ, Blank IH. Permeability of the skin. Physiol Rev. 1971;51(4):702–47.
Scheuplein RJ, Blank IH. Mechanism of percutaneous absorption: IV. Penetration of nonelectrolytes (alcohols) from aqueous solutions and from pure liquids. J Invest Dermatol. 1973;60(5):286–96.
List K, Haudenschild CC, Szabo R, Chen W, Wahl SM, Swaim W, Engelholm LH, Behrendt N, Bugge TH. Matriptase/MT-SP1 is required for postnatal survival, epidermal barrier function, hair follicle development, and thymic homeostasis. Oncogene. 2002;21(23):3765–79.
Tiwary AK, Sapra B, Jain S. Innovations in transdermal drug delivery: formulations and techniques. Recent Pat Drug Deliv Formul. 2007;1:23–36.
Kanikkannan N. Iontophoresis-based transdermal delivery systems. BioDrugs. 2002;16(5):339–47.
Batheja P, Thakur R, Michniak B. Transdermal iontophoresis. Expert Opin Drug Deliv. 2006;3(1):127–38.
Pahade A, Jadhav VM, Kadam VJ. Sonophoresis: an overview. Int J Pharm Sci Rev Res. 2010;3(2):1–32.
Herwadkar A, Sachdeva V, Taylor LF, Silver H, Banga AK. Low frequency sonophoresis mediated transdermal and intradermal delivery of ketoprofen. Int J Pharm. 2012;423(2):289–96.
Holzmann S, Tripp CH, Schmuth M, Janke K, Koch F, Saeland S, Stoitzner P, Romani N. A model system using tape stripping for characterization of Langerhans cell-precursors in vivo. J Invest Dermatol. 2004;122(5):1165–74.
Morgan CJ, Renwick AG, Friedmann PS. The role of stratum corneum and dermal microvascular perfusion in penetration and tissue levels of water-soluble drugs investigated by microdialysis. Br J Dermatol. 2003;148:434–43.
Alvarez-Román R, Naik A, Kalia YN, Guy RH, Fessi H. Enhancement of topical delivery from biodegradable nanoparticles. Pharm Res. 2004;21(10):1818–25.
Liu F, Huang L. Noninvasive gene delivery to the liver by mechanical massage. Hepatology. 2002;35(6):1314–9.
Tinkle SS, Antonini BA, Rich JR, et al. Skin as a route of exposure and sensitization in chronic beryllium disease. Environ Health Perspect. 2003;111:1201–8.
Schneider M, Stracke F, Hansen S, Schaefer UF. Nanoparticles and their interactions with the dermal barrier. Dermatoendocrinology. 2009;1(4):197–206.
Sakurai H, Takahashi Y, Machida Y. Influence of low-frequency massage device on transdermal absorption of ionic materials. Int J Pharm. 2005;305(1–2):112–21.
Baroli B, Ennas MG, Loffredo F, Isola M, Pinna R, López-Quintela MA. Penetration of metallic nanoparticles in human full-thickness skin. J Invest Dermatol. 2007;127:1701–12.
Maia CS, Mehnert W, Sch¨afer-Korting M. Solid lipid nanoparticles as drug carriers for topical glucocorticoids. Int J Pharm. 2000;196:165–7.
Sivaramakrishnan R, Nakamura C, Mehnert W, Korting HC, Kramer KD, Sch¨afer-Korting M. Glucocorticoid entrapment into lipid carriers—characterization by parelectic spectroscopy and influence on dermal uptake. J Control Release. 2004;97:493–502.
Souto EB, Wissing SA, Barbosa CM, M¨uller RH. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int J Pharm. 2004;278:71–7.
Song C, Liu S. A new healthy sunscreen system for human: solid lipid nanoparticles as carrier for 3,4,5-trimethoxybenzoylchitin and the improvement by adding vitamin E. Int J Biol Macromol. 2005;36:116–9.
Chen HB, Chang XL, Yang XL, Du DR, Liu W, Liu J, Weng T, Yang YJ, Xu HB. Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting. J Control Release. 2006;110:296–306.
Liu J, Hu W, Chen H, Ni Q, Xu H, Yang X. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. Int J Pharm. 2007;328(2):191–5.
Lee PY, Zhu Y, Tan J, Sun RWY, Hao W, Liu X, Che CM, Wong KK. The cytotoxic effects of lipidic formulated gold-porphyrin nanoparticles for the treatment of neuroblastoma. Nanotechnol Sci Appl. 2010;3:23–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Lee, P., Nasir, A., Wong, K.K.Y. (2013). Emerging Nanomedicine for Skin Cancer. In: Nasir, A., Friedman, A., Wang, S. (eds) Nanotechnology in Dermatology. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-5034-4_11
Download citation
DOI: https://doi.org/10.1007/978-1-4614-5034-4_11
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-5033-7
Online ISBN: 978-1-4614-5034-4
eBook Packages: MedicineMedicine (R0)